Dachaigh › Aillse Sgamhain Neo-chealla-beag › New York › Albany
Sgrùdaidhean clionaigeach Aillse Sgamhain Neo-chealla-beag ann an Albany, NY
Tha 9 sgrùdaidhean airson Aillse Sgamhain Neo-chealla-beag a’ lorg phàirtichean aig làraichean ann agus timcheall air Albany (taobh a-staigh mu 30 mìle). Fosglaidh sgrùdadh gus faicinn cò as urrainn pàirt a ghabhail agus mar a chuireas tu fios air an sgioba.
Teacsa sgrùdaidh oifigeil (Beurla)
A’ fastadh airson sgrùdadh an seo? Seall e aig mullach na duilleige seo — $99 airson 30 latha →
A Study of Calderasib (MK-1084) Plus Pembrolizumab (MK-3475) in Participants With KRAS G12C Mutant Non-small Cell Lung Cancer (NSCLC) With Programmed Cell Death Ligand 1 (PD-L1) Tumor Proportion Score (TPS) ≥50% (MK-1084-004/KANDLELIT-004)
A’ fastadhÌre 3
- New York Oncology Hematology, P.C. ( Site 0132), Albany
A Clinical Study of Calderasib (MK-1084) and Other Treatments for Participants With Non-Small Cell Lung Cancer (MK-1084-007/KANDLELIT-007)
A’ fastadhÌre 3
- New York Oncology Hematology, P.C. ( Site 0119), Albany
A Clinical Trial of Adjuvant Intismeran (V940) With or Without Pembrolizumab Coformulated With Berahyaluronidase Alfa (MK-3475A) in High-Risk Stage I Non-Small Cell Lung Cancer (V940-014)
A’ fastadhÌre 3
- New York Oncology Hematology, P.C. ( Site 9000), Albany
A Clinical Trial of Calderasib (MK-1084) and Durvalumab in People With Non-Small Cell Lung Cancer (MK-1084-015/KANDLELIT-015)
A’ fastadhÌre 3
- New York Oncology Hematology P.C ( Site 9000), Albany
Symbiotic-Lung-01 : A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer
A’ fastadhÌre 3
- New York Oncology Hematology, Albany
Phase 2 Trial of Adagrasib Monotherapy and in Combination With Pembrolizumab and a Phase 3 Trial of Adagrasib in Combination in Patients With a KRAS G12C Mutation KRYSTAL-7
A’ fastadhÌre 2/3
- New York Oncology Hematology - Albany Medical Center, Albany
Study to Assess the Efficacy and Safety of Rina-S in Participants With Non-small Cell Lung Cancer
A’ fastadhÌre 2
- ONE Onc: New York Oncology Hematology, Albany
MYLUNG Consortium Part 3: Observational Study
A’ fastadhSgrùdadh amharc
- New York Oncology Hematology, P.C., Albany
GEMINI-NSCLC: NSCLC Biomarker Study
A’ fastadhSgrùdadh amharc
- New York Oncology Hematology, Albany
Sgrùdaidhean Aillse Sgamhain Neo-chealla-beag ann am bailtean eile
- Houston, TX145 sgrùdaidhean
- New York City, NY121 sgrùdaidhean
- Arlington, VA104 sgrùdaidhean
- Nashville, TN97 sgrùdaidhean
- Boston, MA90 sgrùdaidhean
- Los Angeles, CA87 sgrùdaidhean
- St. Louis, MO73 sgrùdaidhean
- Chicago, IL61 sgrùdaidhean
- Baltimore, MD60 sgrùdaidhean
- San Antonio, TX59 sgrùdaidhean
- Columbus, OH57 sgrùdaidhean
- Washington, DC55 sgrùdaidhean
Sgrùdaidhean eile ann an Albany
- Galarachd Cardiovasculach7 sgrùdaidhean
- Fàilligeadh a' Chridhe6 sgrùdaidhean
- Obesity6 sgrùdaidhean
- Aillse (gach seòrsa)5 sgrùdaidhean
- Buailteach4 sgrùdaidhean
- Brùthadh-fala àrd4 sgrùdaidhean
- Lymphoma Burkitt4 sgrùdaidhean
- Myeloma iomaill4 sgrùdaidhean
- Galar Alzheimer4 sgrùdaidhean
- Galaran Cnàmhaidh4 sgrùdaidhean
- Aillse sa bhlaire4 sgrùdaidhean
- Aillse a' bhroilleach4 sgrùdaidhean
Bho ClinicalTrials.gov, dàta air a thogail 6 Dàmh 2026. Bidh gach sgrùdadh a’ suidheachadh a chuidi fhèin; bidh an sgioba sgrùdaidh a’ co-dhùnadh cò as urrainn pàirt a ghabhail.